tramadol (Orbis Biosciences)

N/A

Report date: 2025/01/26 17:41:16
NME

Base Information

Drug Nametramadol (Orbis Biosciences)
Drug Alias Nametramadol (Adare Pharmaceuticals)tramadol(Orbis Biosciences)tramadoltramadol (Orbis Biosciences)ORB-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonistsSerotonin reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporterMu opioid receptorSerotonin transporter
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrbis Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdare Pharmaceuticals Inc
Inactive CompaniesOrbis Biosciences Inc
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A